In a historic and surprise move, this week the US declared its support for a patent waiver on COVID-19 vaccines.
Do masks need to be worn outdoors?
Though risk is lower, researchers debate whether people should be encouraged to wear masks outdoors or should efforts instead focus on reducing indoor transmission?
Polls indicate pausing the J&J vaccine was the right decision
While numbers indicate that the risks of COVID-19 still outweigh potential vaccine side effects, the current pause in vaccine distribution demonstrate the system is working and the public is onboard.
Pseudoviruses help determine the success of COVID-19 vaccines and antibody therapies
Assays using pseudoviruses have been indispensable in our efforts to halt the current pandemic.
Delaying second dose of COVID-19 vaccine has benefits in the short term, but depends on immunity
The strength of immune responses after the first dose of COVID-19 vaccines could make or break this strategy and policy makers need to be able to adapt.
What COVID-19 vaccine should I get? Whichever one you are offered, say experts
First and foremost, the goal is to keep people out of hospitals. The good news is all of the currently approved vaccines do just that.
Researchers discover potential SARS-CoV-2 inhibitors
New active substances that can block the replication of the SARS-CoV-2 coronavirus discovered in proof-of-concept study.
Biodegradable masks could help curb the rise in plastic waste
Moisture-resistant mask filters made from compostable and abundant materials could help curb plastic pollution as a result of the pandemic.
How do mutations help SARS-CoV-2 escape our antibodies?
A scientific detective story unearths how SARS-CoV-2 evolves new variants that evade antibodies.
Russian COVID-19 vaccine shows 91.6% efficacy in phase 3 trial
Russia’s Sputnik V coronavirus vaccine gives around 92% protection against COVID-19, results published in The Lancet reveal.